Core AI Holdings Appoints Arie Goor as Chief Financial Officer

Appointment Strengthens Financial Leadership as Company Executes Growth Strategy

Core AI Holdings, Inc. (Nasdaq: CHAI) (“Core AI”), a global AI technology and infrastructure company, today announced the appointment of Arie Goor, CPA, MBA, as its Chief Financial Officer, effective July 1, 2026.

Mr. Goor, 43, joins Core AI Holdings with more than 15 years of executive financial leadership experience spanning corporate finance, capital markets, strategic transactions, and financial management across the biotechnology, medical device, and technology sectors. His appointment further strengthens the Company’s executive leadership team as Core AI continues to scale its operations, expand its market presence, and execute its long-term growth strategy.

“We are pleased to welcome Arie to Core AI Holdings,” said Aitan Zacharin, Chief Executive Officer of Core AI Holdings. “Arie brings a proven track record of financial leadership, capital markets expertise, and strategic execution that will be invaluable as we continue to scale our business. His extensive experience leading public companies, executing complex financing transactions, and strengthening financial operations makes him an outstanding addition to our executive team. We look forward to benefiting from his leadership as we drive shareholder value and capitalize on the significant opportunities ahead.”

Read More on Fintech : Global Fintech Interview with Rob Young, Managing Director – UK at InDebted

Prior to joining Core AI Holdings, Mr. Goor served as Chief Financial Officer of NYSE listed Regentis Biomaterials (RGNT), a regenerative medicine company, from October 2022 until January 2026, and Chief Financial Officer of Revium Rx (Revium Recovery) from June 2023 until May 2026. Throughout his career, he has successfully led numerous initial public offerings and cross-border capital markets transactions on major global exchanges, including NASDAQ, the Australian Securities Exchange (ASX), the TSX Venture Exchange (TSXV), and the Tel Aviv Stock Exchange (TASE).

Mr. Goor also serves as financial advisor to publicly traded companies, including Nasdaq listed Galmed Pharmaceuticals Ltd. (GLMD) and Polyrizon Ltd. (PLRZ), advising management teams and boards on corporate finance, SEC reporting, governance, regulatory compliance, and capital markets strategy.

In his role as Head of the IPO and M&A Department at Shimony Financial Services, who he has been with since 2018, Mr. Goor advised numerous public and private companies on capital markets transactions, mergers and acquisitions, corporate finance, and strategic growth initiatives. He previously served as an Audit Manager at Ernst & Young, specializing in publicly traded and emerging growth companies.

“I am excited to join Core AI Holdings at such a pivotal stage in its growth,” said Mr. Goor. “The Company is well-positioned to capitalize on the expanding opportunities across the artificial intelligence landscape. I look forward to working closely with the leadership team and Board of Directors to strengthen the Company’s financial foundation, support strategic growth initiatives, and create long-term value for shareholders.”

Mr. Goor holds an MBA in Financial Management from Tel Aviv University and a B.A. in Accounting and Economics from the Hebrew University of Jerusalem. He has been a licensed Certified Public Accountant (CPA) since 2012.